Post Archive by Day

Risk for kidney failure with replacement therapy lower with ACEi, ARB treatment among individuals with advanced CKD

Patients with overweight, obesity receiving tirzepatide significantly more likely to achieve ≥5, ≥10, and ≥15 percent weight loss

Initiators of rivaroxaban or warfarin versus apixaban have significantly higher rates of major hemorrhage

Counties without a cardiologist have higher cardiovascular risk index, higher cardiovascular mortality rates, and shorter life expectancy